The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Shopping
    • Stores
    • Coupons
    • Daily Double
    • Promotion
    • How It Works
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • Sports

    KNOTT: Pollin honored as a D.C. treasure

  • Sports

    Jamison lights fire under Wizards

  • Politics

    Uninvited White House guests met Obama in line

  • Sports

    Wife aids Woods after SUV crash

  • National

    Volunteers for drug trials hard to find

  • Business

    Dubai debt crisis rocks U.S., Asia markets

  • World

    Piracy threatens fishermen in Yemen

Monday, April 10, 2006

Abortion pill, death not linked, FDA says

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos

More Stories

  • 3 Americans die in cargo plane crash in China
  • White House: Ticketless couple met Obama
  • Atlantis, crew of 7 back on Earth
  • Uninvited White House guests met Obama in line

By

ASSOCIATED PRESS

Health officials said yesterday that they have ruled out the abortion pill RU-486 in one of two deaths in women who took the drug. The second remains under investigation.

One death was unrelated to either abortion or use of the pill, the Food and Drug Administration said. The second woman showed symptoms of infection. Four other women have died of infections after undergoing pill-triggered abortions.

In those four deaths, all involving Californians, the women tested positive for Clostridium sordellii, a common but rarely fatal bacterium.

The FDA has warned doctors to watch for infection by the bug. However, the drug, also called Mifeprex or mifepristone, has not been proved to be the cause in any of those cases, the FDA has said.

The recent deaths sparked new calls to ban the abortion pill.

Republican Sens. Jim DeMint of South Carolina and Tom Coburn of Oklahoma urged passage of legislation that would suspend sales of RU-486 after the latest deaths were made public in March. The two legislators want the Government Accountability Office to review how the FDA approved the pill.

The FDA approved RU-486 in 2000 for use in ending a pregnancy up to 49 days after the beginning of the latest menstrual cycle.

Neither of the two women followed FDA-approved instructions for the pill, which require swallowing three tablets of one drug, followed by two of another two days later.

Instead of swallowing the final two tablets, the second course of pills was inserted vaginally in the four women, an "off-label" use that studies have shown as effective and that has been recommended by a majority of the nation's abortion clinics. That use does not have federal approval, though studies have indicated it produces fewer side effects.

Planned Parenthood Federation of America Inc. said it immediately would stop recommending vaginal insertion of the final course of pills. Four of the women who died, including the latest two, received the pills at Planned Parenthood-affiliated clinics. Planned Parenthood estimates that RU-486 has been used 560,000 times in the United States since it was approved.

RU-486 is sold by Danco Laboratories. It works by blocking a hormone required to sustain a pregnancy. When followed two days later by another medicine, misoprostol, to induce contractions, the pregnancy is terminated.

Federal health officials plan a May 11 workshop in Atlanta to discuss emerging cases of disease involving C. sordellii, which also have included infections in patients who have received skin grafts.

Post a comment

There are comments on this article, submit your opinion!

Commenting is disabled for this entry.
If you feel there is still something worth mentioning about this entry please contact the author or the site admin.

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. EDITORIAL: Hiding evidence of global cooling
  2. EDITORIAL: The global-cooling cover-up
  3. Climate 'czar' says hacked e-mails don't change anything
  4. Wife aids Woods after SUV crash
  5. PRUDEN: Trouble afoot for high priests
More Top Stories »
  1. In tobacco-loving Virginia, bars give up the habit
  2. Grade-schooler unearths fossil at dinosaur park
  3. Robotic hamster holiday craze
  4. Fenty's approval in D.C. divided by race
  5. Climate czar rejects doctored data claims

Most Shared

  1. PRUDEN: Trouble afoot for high priests
  2. EDITORIAL: The global-cooling cover-up
  3. EDITORIAL: Hiding evidence of global cooling
  4. University bubble bursting?
  5. Robotic hamster holiday craze
More Top Stories »
  1. In tobacco-loving Virginia, bars give up the habit
  2. We ain't seen nothing yet
  3. Climate 'czar' says hacked e-mails don't change anything
  4. Dubai debt crisis rocks U.S., Asia markets
  5. CHANDLER: The Cloward-Piven strategy

Most Commented

  1. EDITORIAL: The global-cooling cover-up
  2. Climate 'czar' says hacked e-mails don't change anything
  3. PRUDEN: Trouble afoot for high priests
  4. Crashers probe may become criminal investigation
  5. Grayson's Senate filibuster petition faulted
More Top Stories »
  1. Fenty's approval in D.C. divided by race
  2. Ads add heat to health care debate
  3. EDITORIAL: Hiding evidence of global cooling
  4. Health, climate bills seen to stifle hiring
  5. On Afghan war decision, stakes never higher for Obama

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Blogs & Columns

  • Hot Button Blog

    RNC: Breast cancer recommendations may lead to 'rationing'

  • Belief Blog

    Evangelicals OK civil disobedience

  • Out of Context

    Foods that might kill libido

  • On the Fly

    United lifts some 'award' blocking

  • Technology

    Facebook wins round against phishing spammer

  • Redskins 360

    Gray staying put

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.